Takala, S. L., Coulibaly, D., Thera, M. A., Batchelor, A. H., Cummings, M. P., Escalante, A. A., . . . Plowe, C. V. (2009). Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development.
Chicago-стиль цитированияTakala, Shannon L., et al. Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development. 2009.
MLA-цитированиеTakala, Shannon L., et al. Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development. 2009.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.